Laurus Labs Limited updates on inspection at Formulations Facility

Laurus Labs Limited has announced that the United States Food & Drug Administration (USFDA) completed inspection of the formulations manufacturing facility Unit-2, APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh. The inspection was conducted from 6th February, 2023 to 10th February, 2023. We have been issued a Form 483 with two observations. The observations are procedural in nature. The Company will address the observations within stipulated timelines.

Shares of Laurus Labs Limited was last trading in BSE at Rs. 340.25 as compared to the previous close of Rs. 338.25. The total number of shares traded during the day was 23767 in over 796 trades.

The stock hit an intraday high of Rs. 342.60 and intraday low of 334.00. The net turnover during the day was Rs. 8056264.00.

Source : Equity Bulls

Keywords

LaurusLabs INE947Q01028 USFDA Inspection FormulationsFacility Atchutapuram Vizag